sunbet

sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Á¬Ã¦ËÑË÷
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Á¬Ã¦ËÑË÷
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
ÂöÂçĤºÚËØÁö¶¯ÎïÄ£×Ó
Ä¿½ñλÖãºÊ×Ò³ > ÈËÀ༲²¡¶¯ÎïÄ£×ÓĿ¼ > ÑۿƼ²²¡Ä£×Ó > ÂöÂçĤºÚËØÁö¶¯ÎïÄ£×Ó

ǰÑÔ

ÑÛ²¿½á¹¹Öش󣬷¢ÓýʱÀ´×ÔÈý¸öÅ߲㣺±íƤÍâÅßÒ¶Ðγɾ§×´Ìå¡¢ÀáÏÙ¡¢½ÇĤºÍÑÛíúÉÏÆ¤²ãÒÔ¼°½áĤºÍÆäÁ¥ÊôÏÙÌå £»Éñ¾­ÍâÅßÒ¶ÐγÉÊÓÍøÄ¤¡¢Í«¿×¿ª´ó¼¡ºÍÀ¨Ô¼¼¡ £»ÖÐÅßÒ¶ÐγÉÑÛÍ⼡¡¢ÑÛ¿ôºÍѪ¹Ü¡£Òò¶øÑÛ²¿ËäȻС£¬µ«±¬·¢µÄÖ×Áö¶àÑù¡£³£¼ûµÄÓÐÑÛíúµÄ»ùÄÚÇé°û°©¡¢íú°åÏÙ°© £»½Ç½áĤµÄÁÛ×´ÉÏÆ¤°©¡¢ºÚËØÁö £»¿ô×éÖ¯µÄ¶ñÐÔѪ¹ÜÄÚÆ¤Áö¡¢ÀáÏÙÏÙ°©¡¢ºáÎÆ¼¡ÈâÁö £»Éñ¾­ÈªÔ´µÄ¶ñÐÔ½ºÖÊÁö¡¢Ëèĸϸ°ûÁö¡£ÕâЩÖ×Áö±¬·¢ÓÚÑÛ²¿£¬µ«¶¼ºÍÈ«ÉíÆäËûϵͳÖ×Áö±£´æ½»¼¯£¬²»ÎªÑÛ¿ÆËùÌØÓС£Ó¤Ó×¶ùÑÛ²¿×î³£¼ûµÄÊÇÊÓÍøÄ¤Ä¸Ï¸°ûÁö£¬³ÉÈËΪÂöÂçºÚËØÁö¡£

ÂöÂçĤºÚËØÁö(choroid melanoma)º£Äڵķ¢²¡Âʽö´ÎÓÚ±¬·¢ÔÚ¶ùͯµÄÊÓÍøÄ¤Ä¸Ï¸°ûÁö£¬ÊdzÉÈË×î³£¼ûµÄÑÛÄÚ¶ñÐÔÖ×Áö¡£Ö×ÁöµÄÔ¤ºóÓëÁöÌåµÄ¾ÞϸÒÔ¼°Áöϸ°û²¡ÀíÀàÐÍÓйØ¡£ËóÐÎϸ°ûÐÍ5Äê´æ»îÂÊΪ84£¥ £»»ìÏýϸ°ûÐͺͻµËÀÐÍ5Äê´æ»îÂÊΪ50£¥×óÓÒ £»ÉÏÆ¤ÑùÁöϸ°ûÐÍ5Äê´æ»îÂʵÍÓÚ30£¥£¬Ô¤ºó×î²î¡£ÂöÂçĤºÚËØÁö¶¯ÎïÄ£×ÓÆ¾Ö¤ÓÕ·¢»úÖÆ¿É·ÖÎªÒÆÖ²ÐÔÄ£×Ó¡¢×ª»ùÒòÄ£×ÓºÍÓÕ·¢ÐÔÄ£×Ó¡£

²¿·ÖÔìÄ£ÒªÁì

ʹÓö¯ÎСÊó

¡¾ÔìÄ £»úÖÆ¡¿£º

ÒÆÖ²ÐÔÄ£×ÓÒ²ÊǽÓÄÉÂãСÊ󣬻ùÒòÐÞÊÎÄ£×ÓÒ²·ÖΪת»ùÒòºÍ»ùÒòÇóýСÊ󣬻úÖÆÓëRBÒ»Ñù¡£²¿·Ö¶¯Îï²£Á§ÌåÇ»ÄÚ×¢ÉäÄøÁòÇ⻯Îï(Ni3S3)ºóÒ²¿ÉÓÕ·¢³öÂöÂçĤºÚÁö¡£Ä÷ÔÚÈËÀàÊÂÇéºÍÉúÑÄÇéÐÎÖÐÆÕ±é±£´æ£¬¼ÈÊÇÈËÀ಻¿Éȱ°±ÉÄ΢Á¿ÔªËØ£¬Ò²¾ßÓкÜÇ¿µÄÖ°©ÐÔ£¬ÆäÖÐNi3S3µÄÖ°©ÐÔ×îÇ¿¡£ÄøÖ°©µÄ»úÖÆ°üÀ¨£ºÓÕµ¼Í»±ä½ø¶øµ¼ÖÂÖ×ÁöÏà¹Ø»ùÒò±í´ïÒì³£ £»ÓÕµ¼Ï¸°û±¬·¢Ñõ×ÔÓÉ»ù£¬µ¼ÖÂDNAËðÉË¡¢È¾É«Ìå¶ÏÁÑ £»ÓÕµ¼Ï¸°ûÄÚNF-KBµÄ±í´ïµ¼ÖÂÖ×ÁöµÄÐγÉ¡£³ýÁËÖ±½ÓÓÕµ¼»ùÒò×éµÄ¸Ä±ä£¬Äø»¹¿ÉÒÔͨ¹ý±í¹ÛÒÅ´«Ñ§µÄ¸Ä±ä£¬¼Ì¶øÓ°Ïì°©Ïà¹Ø»ùÒòµÄ±í´ï¡£

¡¾ÔìÄ£ÒªÁì¡¿£º

Ñ¡Óÿµ½¡SPF¼¶´óÊó£¬Âé×íºó¿ªÁ³Æ÷³Å¿ªÑÛíú£¬¾­9µãλ½ÇĤԵºó΢Á¿×¢ÉäÆ÷×¢ÈëNi3S3¡£Ni3S3½ÓÄÉÐÄÀíÑÎË®ÅäÖÆ³É»ìÐüÒº£¬×¢ÈëÁ¿Îª10μl£¬Å¨¶ÈΪ50mg/ml¡£

¡¾Ä£×ÓÌØµã¡¿£º

6~9¸öÔ²£Á§ÌåÄÚ¿ÉÖð½¥·ºÆðÖ×Áö£¬ËæºóÖ×ÁöÉú³¤Ñ¸ËÙ£¬¿É³äÂúÑÛÇò²¢ÇÖÕ¼ÑÛ¿ô£¬²¿·ÖÄ£×Ó¶¯Îï¿É¼ì²âµ½¸Î¡¢·ÎºÍÄÔ×ªÒÆ¡£²¡ÀíÌØµãΪËóÐκÍÉÏÆ¤ÐÔϸ°û¡£

¡¾Ä£×ÓÆÀ¹ÀºÍÓ¦Óá¿£º

±¾Ä£×ÓÊÇÒ»ÖֺܺõÄÑо¿»¯Ñ§ÎïÖʵ¼ÖÂÂöÂçĤºÚËØÁö±¬·¢µÄÄ£×Ó£¬ÊµÑ鶯ÎïºÍNi3S3×ÔÖÆÒ׵ᣵ«¶¯ÎïÑÛÇò½ÏС£¬ÊÖÊõ´´É˺ÍËæºóµÄ²¡Àí¸Ä±ä¿ÉÄܵ¼ÖÂÔìģʧ°Ü¡£ÁíÍ⣬ÔÚÓÕµ¼³öºÚËØÁöµÄͬʱ£¬»¹»á°éÓÐÆäËûÀàÐÍÖ×Áö¡£

 

²Î¿¼ÎÄÏ×£º

1.ÕŲ¨£¬ÖÓÐã·ç£¬ÀîÓÀƽ£¬µÈ£®ÊÓÍøÄ¤Ä¸Ï¸°ûÁöSO-RB50Áöϸ°ûNOD-SCIDÊóƤÏÂÒìÎ»ÒÆÖ²È«Éí×ªÒÆÁöÄ£×ӵĽ¨É裮¹ú¼ÊÑÛ¿ÆÔÓÖ¾£¬2005,5 (4):638-642

2.Ö£áÔɽ£¬ÎâÖÐÒ«£¬Ñʤ£¬µÈ£®ÍÃÑÛǰ·¿ÊÓÍøÄ¤Ä¸Ï¸°ûÁö¶¯ÎïÄ£×ӵĽ¨É裮ÑÛ¿ÆÑо¿£¬2008, 26 (1):35-38

3.¸ð˳骣¬Äþ±±·¼£¬¶¡¾¢£¬µÈÄøÖ°©»úÖÆµÄÑо¿Ï£Íû. Ö×ÁöѧÔÓÖ¾£¬2007, 13 (1):74-78

4.Albert OM. Needs for animal models of human diseases of the eye:induced animal models of human ocular disease with particular consideration of ocular melanoma. Am J PaLhol, 1980,101 (3): 177-185

5.Ivanova IA,D'Souza SJ,Dagnino L. Signalliag in the epidermis: the E2F cell cycle regulatory pathway in epidennal morphogenesis, regeneration and¶©ansfonnation. Int J Biol Sci, 2005, 1(2):87-95

6.Marcus DM,Lasudry JG,Carpenter JL,et al. Trilateraltumors in four different lines of transgenic mice expressing SV40 T-antigen. Invest Ophthalmol Vis Sci,1996, 37 (2):392-396

7.Raabe OG. Comparison of the carcinogenicity of radiumand bone-seeking actinides. Health Phys, 1984,46(6): 1241-1258

8.Taylor GN, Lloyd RD, Miller SC,et al. Radium-induced eye melanomas in dogs. Health Phys,2000, 79 (2):196-198

sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Ä£×ÓĿ¼
Ä¿½ñλÖãºÊ×Ò³ > ÈËÀ༲²¡¶¯ÎïÄ£×ÓĿ¼ > ÑۿƼ²²¡Ä£×Ó > ÂöÂçĤºÚËØÁö¶¯ÎïÄ£×Ó
ÂöÂçĤºÚËØÁö¶¯ÎïÄ£×Ó

ǰÑÔ

ÑÛ²¿½á¹¹Öش󣬷¢ÓýʱÀ´×ÔÈý¸öÅ߲㣺±íƤÍâÅßÒ¶Ðγɾ§×´Ìå¡¢ÀáÏÙ¡¢½ÇĤºÍÑÛíúÉÏÆ¤²ãÒÔ¼°½áĤºÍÆäÁ¥ÊôÏÙÌå £»Éñ¾­ÍâÅßÒ¶ÐγÉÊÓÍøÄ¤¡¢Í«¿×¿ª´ó¼¡ºÍÀ¨Ô¼¼¡ £»ÖÐÅßÒ¶ÐγÉÑÛÍ⼡¡¢ÑÛ¿ôºÍѪ¹Ü¡£Òò¶øÑÛ²¿ËäȻС£¬µ«±¬·¢µÄÖ×Áö¶àÑù¡£³£¼ûµÄÓÐÑÛíúµÄ»ùÄÚÇé°û°©¡¢íú°åÏÙ°© £»½Ç½áĤµÄÁÛ×´ÉÏÆ¤°©¡¢ºÚËØÁö £»¿ô×éÖ¯µÄ¶ñÐÔѪ¹ÜÄÚÆ¤Áö¡¢ÀáÏÙÏÙ°©¡¢ºáÎÆ¼¡ÈâÁö £»Éñ¾­ÈªÔ´µÄ¶ñÐÔ½ºÖÊÁö¡¢Ëèĸϸ°ûÁö¡£ÕâЩÖ×Áö±¬·¢ÓÚÑÛ²¿£¬µ«¶¼ºÍÈ«ÉíÆäËûϵͳÖ×Áö±£´æ½»¼¯£¬²»ÎªÑÛ¿ÆËùÌØÓС£Ó¤Ó×¶ùÑÛ²¿×î³£¼ûµÄÊÇÊÓÍøÄ¤Ä¸Ï¸°ûÁö£¬³ÉÈËΪÂöÂçºÚËØÁö¡£

ÂöÂçĤºÚËØÁö(choroid melanoma)º£Äڵķ¢²¡Âʽö´ÎÓÚ±¬·¢ÔÚ¶ùͯµÄÊÓÍøÄ¤Ä¸Ï¸°ûÁö£¬ÊdzÉÈË×î³£¼ûµÄÑÛÄÚ¶ñÐÔÖ×Áö¡£Ö×ÁöµÄÔ¤ºóÓëÁöÌåµÄ¾ÞϸÒÔ¼°Áöϸ°û²¡ÀíÀàÐÍÓйØ¡£ËóÐÎϸ°ûÐÍ5Äê´æ»îÂÊΪ84£¥ £»»ìÏýϸ°ûÐͺͻµËÀÐÍ5Äê´æ»îÂÊΪ50£¥×óÓÒ £»ÉÏÆ¤ÑùÁöϸ°ûÐÍ5Äê´æ»îÂʵÍÓÚ30£¥£¬Ô¤ºó×î²î¡£ÂöÂçĤºÚËØÁö¶¯ÎïÄ£×ÓÆ¾Ö¤ÓÕ·¢»úÖÆ¿É·ÖÎªÒÆÖ²ÐÔÄ£×Ó¡¢×ª»ùÒòÄ£×ÓºÍÓÕ·¢ÐÔÄ£×Ó¡£

²¿·ÖÔìÄ£ÒªÁì

ʹÓö¯ÎСÊó

¡¾ÔìÄ £»úÖÆ¡¿£º

ÒÆÖ²ÐÔÄ£×ÓÒ²ÊǽÓÄÉÂãСÊ󣬻ùÒòÐÞÊÎÄ£×ÓÒ²·ÖΪת»ùÒòºÍ»ùÒòÇóýСÊ󣬻úÖÆÓëRBÒ»Ñù¡£²¿·Ö¶¯Îï²£Á§ÌåÇ»ÄÚ×¢ÉäÄøÁòÇ⻯Îï(Ni3S3)ºóÒ²¿ÉÓÕ·¢³öÂöÂçĤºÚÁö¡£Ä÷ÔÚÈËÀàÊÂÇéºÍÉúÑÄÇéÐÎÖÐÆÕ±é±£´æ£¬¼ÈÊÇÈËÀ಻¿Éȱ°±ÉÄ΢Á¿ÔªËØ£¬Ò²¾ßÓкÜÇ¿µÄÖ°©ÐÔ£¬ÆäÖÐNi3S3µÄÖ°©ÐÔ×îÇ¿¡£ÄøÖ°©µÄ»úÖÆ°üÀ¨£ºÓÕµ¼Í»±ä½ø¶øµ¼ÖÂÖ×ÁöÏà¹Ø»ùÒò±í´ïÒì³£ £»ÓÕµ¼Ï¸°û±¬·¢Ñõ×ÔÓÉ»ù£¬µ¼ÖÂDNAËðÉË¡¢È¾É«Ìå¶ÏÁÑ £»ÓÕµ¼Ï¸°ûÄÚNF-KBµÄ±í´ïµ¼ÖÂÖ×ÁöµÄÐγÉ¡£³ýÁËÖ±½ÓÓÕµ¼»ùÒò×éµÄ¸Ä±ä£¬Äø»¹¿ÉÒÔͨ¹ý±í¹ÛÒÅ´«Ñ§µÄ¸Ä±ä£¬¼Ì¶øÓ°Ïì°©Ïà¹Ø»ùÒòµÄ±í´ï¡£

¡¾ÔìÄ£ÒªÁì¡¿£º

Ñ¡Óÿµ½¡SPF¼¶´óÊó£¬Âé×íºó¿ªÁ³Æ÷³Å¿ªÑÛíú£¬¾­9µãλ½ÇĤԵºó΢Á¿×¢ÉäÆ÷×¢ÈëNi3S3¡£Ni3S3½ÓÄÉÐÄÀíÑÎË®ÅäÖÆ³É»ìÐüÒº£¬×¢ÈëÁ¿Îª10μl£¬Å¨¶ÈΪ50mg/ml¡£

¡¾Ä£×ÓÌØµã¡¿£º

6~9¸öÔ²£Á§ÌåÄÚ¿ÉÖð½¥·ºÆðÖ×Áö£¬ËæºóÖ×ÁöÉú³¤Ñ¸ËÙ£¬¿É³äÂúÑÛÇò²¢ÇÖÕ¼ÑÛ¿ô£¬²¿·ÖÄ£×Ó¶¯Îï¿É¼ì²âµ½¸Î¡¢·ÎºÍÄÔ×ªÒÆ¡£²¡ÀíÌØµãΪËóÐκÍÉÏÆ¤ÐÔϸ°û¡£

¡¾Ä£×ÓÆÀ¹ÀºÍÓ¦Óá¿£º

±¾Ä£×ÓÊÇÒ»ÖֺܺõÄÑо¿»¯Ñ§ÎïÖʵ¼ÖÂÂöÂçĤºÚËØÁö±¬·¢µÄÄ£×Ó£¬ÊµÑ鶯ÎïºÍNi3S3×ÔÖÆÒ׵ᣵ«¶¯ÎïÑÛÇò½ÏС£¬ÊÖÊõ´´É˺ÍËæºóµÄ²¡Àí¸Ä±ä¿ÉÄܵ¼ÖÂÔìģʧ°Ü¡£ÁíÍ⣬ÔÚÓÕµ¼³öºÚËØÁöµÄͬʱ£¬»¹»á°éÓÐÆäËûÀàÐÍÖ×Áö¡£

 

²Î¿¼ÎÄÏ×£º

1.ÕŲ¨£¬ÖÓÐã·ç£¬ÀîÓÀƽ£¬µÈ£®ÊÓÍøÄ¤Ä¸Ï¸°ûÁöSO-RB50Áöϸ°ûNOD-SCIDÊóƤÏÂÒìÎ»ÒÆÖ²È«Éí×ªÒÆÁöÄ£×ӵĽ¨É裮¹ú¼ÊÑÛ¿ÆÔÓÖ¾£¬2005,5 (4):638-642

2.Ö£áÔɽ£¬ÎâÖÐÒ«£¬Ñʤ£¬µÈ£®ÍÃÑÛǰ·¿ÊÓÍøÄ¤Ä¸Ï¸°ûÁö¶¯ÎïÄ£×ӵĽ¨É裮ÑÛ¿ÆÑо¿£¬2008, 26 (1):35-38

3.¸ð˳骣¬Äþ±±·¼£¬¶¡¾¢£¬µÈÄøÖ°©»úÖÆµÄÑо¿Ï£Íû. Ö×ÁöѧÔÓÖ¾£¬2007, 13 (1):74-78

4.Albert OM. Needs for animal models of human diseases of the eye:induced animal models of human ocular disease with particular consideration of ocular melanoma. Am J PaLhol, 1980,101 (3): 177-185

5.Ivanova IA,D'Souza SJ,Dagnino L. Signalliag in the epidermis: the E2F cell cycle regulatory pathway in epidennal morphogenesis, regeneration and¶©ansfonnation. Int J Biol Sci, 2005, 1(2):87-95

6.Marcus DM,Lasudry JG,Carpenter JL,et al. Trilateraltumors in four different lines of transgenic mice expressing SV40 T-antigen. Invest Ophthalmol Vis Sci,1996, 37 (2):392-396

7.Raabe OG. Comparison of the carcinogenicity of radiumand bone-seeking actinides. Health Phys, 1984,46(6): 1241-1258

8.Taylor GN, Lloyd RD, Miller SC,et al. Radium-induced eye melanomas in dogs. Health Phys,2000, 79 (2):196-198

¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿